ophthalmology

eye eyeball eye art
Biotech

Aurion's regenerative med improves vision in phase 1/2 trial

The highest dose of Aurion’s cell therapy, the main component of which recently received approval in Japan, improved vision in a type of eye disease.
James Waldron Dec 18, 2024 7:00am
black and white art of eyes

2 eye disease biotechs merge, set sights on FDA approval

Dec 12, 2024 11:05am
eye eyeball eye art

China-based biotech plans ph. 3 after seeing midstage eye data

Oct 22, 2024 10:37am
water drain

Phase 2 fail sends OcuTerra's eye drop dreams down the drain

Mar 14, 2024 9:15am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

Eyconis launches with $150M and Ascendis' eye disease meds

Jan 29, 2024 11:03am
eye see vision pupil eyelash

iuvo BioScience acquires ophthalmology CRO Promedica

Jan 24, 2024 9:49am